# Fresenius Medical Care AG: Form 20-F for the period ended Dec 31, 2020

- Company: [Fresenius Medical Care AG](/companies/fms.md) (CIK 1333141)
- Form: 20-F
- Filed: 2021-02-23
- Accepted by EDGAR: Feb 23, 2021, 13:51 ET
- Period: 2020-12-31
- Accession: 0001047469-21-000424
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1333141/000104746921000424/a2242850z20-f.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1333141/000104746921000424/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2020-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 12 months, 2020-01-01 to 2020-12-31 | EUR 17.86bn | ifrs-full:Revenue |
| Cost of revenue | 12 months, 2020-01-01 to 2020-12-31 | EUR 12.32bn | ifrs-full:CostOfSales |
| Gross profit | 12 months, 2020-01-01 to 2020-12-31 | EUR 5.54bn | ifrs-full:GrossProfit |
| Operating income | 12 months, 2020-01-01 to 2020-12-31 | EUR 2.30bn | ifrs-full:ProfitLossFromOperatingActivities |
| Income tax | 12 months, 2020-01-01 to 2020-12-31 | EUR 500.6m | ifrs-full:IncomeTaxExpenseContinuingOperations |
| Net income | 12 months, 2020-01-01 to 2020-12-31 | EUR 1.16bn | ifrs-full:ProfitLossAttributableToOwnersOfParent |
| Diluted EPS | 12 months, 2020-01-01 to 2020-12-31 | EUR 3.96 | ifrs-full:DilutedEarningsLossPerShare |
| Basic EPS | 12 months, 2020-01-01 to 2020-12-31 | EUR 3.96 | ifrs-full:BasicEarningsLossPerShare |
| Operating cash flow | 12 months, 2020-01-01 to 2020-12-31 | EUR 4.23bn | ifrs-full:CashFlowsFromUsedInOperatingActivities |
| Cash and equivalents | at 2020-12-31 | EUR 1.08bn | ifrs-full:CashAndCashEquivalents |
| Current assets | at 2020-12-31 | EUR 7.28bn | ifrs-full:CurrentAssets |
| Total assets | at 2020-12-31 | EUR 31.69bn | ifrs-full:Assets |
| Current liabilities | at 2020-12-31 | EUR 6.16bn | ifrs-full:CurrentLiabilities |
| Total liabilities | at 2020-12-31 | EUR 19.36bn | ifrs-full:Liabilities |
| Shareholders' equity | at 2020-12-31 | EUR 11.22bn | ifrs-full:EquityAttributableToOwnersOfParent |
| Shares outstanding | at 2020-12-31 | 292,876,570 shares | dei:EntityCommonStockSharesOutstanding |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1333141/000104746921000424/a2242850z20-f.htm

Filed Feb 23, 2021.
Source: SEC EDGAR, the filing index for accession 0001047469-21-000424. Last ingested by Listed: Nov 10, 2026, 00:27 ET. No prices; not investment advice.